Intratio
Loading...
Skip to main content
Model output · Signal date Oct. 15, 2026

Daily Signals

2630 companies scored · 2026-10-15 run in progress: 5102 of ~5380 signals so far · Total · absolute moveSwitch to Alpha · 30D 90D

Signal date 2026-10-15 Cut-offs from the 2026-10-15 run
Companies scored 2630 IC ≥ 0 · market cap ≥ $100M
Median forecast +0.92% Total · 30D
Long–short spread +2.24% Strong Buy minus Strong Sell, mean
Median IC 0.22 Spearman · 30D
Rating changes ▲ 336 ▼ 633 vs the previous run
Cross-section

Distribution of the day's forecasts

30D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Signals · All

2630 companies

Sorted by market cap ↓ · forecast rankings are part of the paid plans

# Ticker Sector IC Mkt cap Rating 30D 90D Δ
2001 GOODGLADSTONE COMMERCIAL CORP Real Estate & Construction 0.03 $612M Unlock rating and forecasts
2002 MAMAMama's Creations, Inc. Manufacturing 0.19 $612M Neutral +1.08% +2.93% ·
2003 NRDSNERDWALLET, INC. Technology 0.40 $610M Neutral +1.10% +3.16% ·
2004 DSGNDesign Therapeutics, Inc. Life Sciences 0.23 $609M Unlock rating and forecasts
2005 WVEWave Life Sciences, Inc. Life Sciences 0.50 $609M Neutral +0.90% +1.97% ▼ 1
2006 EACOEACO CORP Trade & Services 0.02 $608M Unlock rating and forecasts
2007 ZVRAZEVRA THERAPEUTICS, INC. Life Sciences 0.28 $608M Unlock rating and forecasts
2008 SSYSSTRATASYS LTD. Technology 0.21 $606M Unlock rating and forecasts
2009 NTGRNETGEAR, INC. Technology 0.17 $603M Unlock rating and forecasts
2010 BLZEBackblaze, Inc. Technology 0.30 $602M Unlock rating and forecasts
2011 HYLNHyliion Holdings Corp. Manufacturing -0.12 $602M Unlock rating and forecasts
2012 PHATPhathom Pharmaceuticals, Inc. Life Sciences 0.22 $599M Neutral +0.99% +3.63% ·
2013 IVRInvesco Mortgage Capital Inc. Real Estate & Construction 0.28 $598M Unlock rating and forecasts
2014 OLMAOlema Pharmaceuticals, Inc. Life Sciences 0.54 $595M Unlock rating and forecasts
2015 IRWDIRONWOOD PHARMACEUTICALS INC Life Sciences 0.20 $595M Neutral +0.81% +2.80% ▼ 1
2016 IBEXIBEX Ltd Technology -0.08 $594M Neutral +0.98% +2.79% ·
2017 GILTGILAT SATELLITE NETWORKS LTD Manufacturing 0.24 $591M Neutral +1.03% +3.47% ▼ 2
2018 WEAVWeave Communications, Inc. Technology 0.18 $591M Unlock rating and forecasts
2019 CLYMClimb Bio, Inc. Life Sciences 0.29 $591M Unlock rating and forecasts
2020 HPPHudson Pacific Properties, Inc. Real Estate & Construction 0.34 $591M Unlock rating and forecasts
2021 MLRMILLER INDUSTRIES INC /TN/ Manufacturing 0.16 $589M Neutral +1.00% +3.18% ·
2022 CEPFCantor Equity Partners IV, Inc. Real Estate & Construction -0.19 $587M Unlock rating and forecasts
2023 SLDBSolid Biosciences Inc. Life Sciences 0.43 $586M Unlock rating and forecasts
2024 HNRGHALLADOR ENERGY CO Energy & Transportation 0.19 $586M Unlock rating and forecasts
2025 KIDSORTHOPEDIATRICS CORP Industrial Applications and Services 0.12 $581M Neutral +1.06% +2.83% ·
2026 KRNYKearny Financial Corp. Finance 0.28 $580M Neutral +0.68% +3.22% ▲ 1
2027 FBIZFIRST BUSINESS FINANCIAL SERVICES, INC. Finance -0.04 $580M Neutral +1.09% +2.98% ▲ 1
2028 FLGTFulgent Genetics, Inc. Industrial Applications and Services 0.30 $578M Unlock rating and forecasts
2029 SHENSHENANDOAH TELECOMMUNICATIONS CO/VA/ Technology 0.13 $576M Unlock rating and forecasts
2030 CRMDCorMedix Inc. Life Sciences 0.08 $576M Unlock rating and forecasts
2031 IIININSTEEL INDUSTRIES INC Manufacturing 0.31 $576M Unlock rating and forecasts
2032 VELVelocity Financial, Inc. Finance or Crypto Assets 0.39 $574M Neutral +0.94% +2.07% ·
2033 LMBLimbach Holdings, Inc. Real Estate & Construction 0.18 $571M Unlock rating and forecasts
2034 HOVHOVNANIAN ENTERPRISES INC Real Estate & Construction 0.36 $570M Unlock rating and forecasts
2035 PRMEPrime Medicine, Inc. Life Sciences 0.25 $568M Unlock rating and forecasts
2036 EBFENNIS, INC. Manufacturing 0.07 $566M Unlock rating and forecasts
2037 BWBBridgewater Bancshares Inc Finance 0.12 $562M Unlock rating and forecasts
2038 SFSTSOUTHERN FIRST BANCSHARES INC Finance 0.17 $561M Unlock rating and forecasts
2039 CSVCARRIAGE SERVICES INC Trade & Services 0.07 $560M Unlock rating and forecasts
2040 JBIJanus International Group, Inc. Manufacturing 0.36 $559M Unlock rating and forecasts
2041 ABTCAmerican Bitcoin Corp. Finance or Crypto Assets 0.12 $557M Unlock rating and forecasts
2042 BXCBlueLinx Holdings Inc. Trade & Services 0.33 $556M Unlock rating and forecasts
2043 XPERAdeia Inc. Technology 0.13 $556M Unlock rating and forecasts
2044 LPTHLIGHTPATH TECHNOLOGIES INC Manufacturing 0.07 $555M Unlock rating and forecasts
2045 IVAInventiva S.A. Life Sciences 0.25 $555M Neutral +0.79% +1.89% ·
2046 TROXTronox Holdings plc Industrial Applications and Services 0.51 $551M Unlock rating and forecasts
2047 WTIW&T OFFSHORE INC Energy & Transportation 0.60 $551M Unlock rating and forecasts
2048 CIVBCIVISTA BANCSHARES, INC. Finance 0.10 $550M Neutral +0.81% +2.38% ·
2049 HYHYSTER-YALE, INC. Technology 0.52 $550M Unlock rating and forecasts
2050 OOMAOOMA INC Technology 0.15 $549M Neutral +1.06% +5.00% ·
2001–2050 of 2630 Previous Next
Since the previous run

Rating changes

▲ 336▼ 633
Which companies were upgraded or downgraded is part of the paid plans.
Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account
Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-15) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected absolute price move over the horizon, market included. This is the number a price target is built from. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.